Chris Huang
About Chris Huang
Chris Huang is the Director of Translational Medicine & Hematology Disease Strategy at Bristol Myers Squibb, with extensive experience in the pharmaceutical industry and academia.
Current Role at Bristol Myers Squibb
Chris Huang serves as the Director of Translational Medicine & Hematology Disease Strategy at Bristol Myers Squibb. In this role, he oversees strategic initiatives within the field of hematology, directing the integration of translational science into drug development. His responsibilities include business planning, resource forecasting, and ensuring the alignment of team performance with organizational timelines.
Previous Experience at Celgene
From 2017 to 2019, Chris Huang was the Associate Director of Translational Development at Celgene, focusing on B Cell Malignancy. During his tenure, he led pivotal projects aimed at advancing the understanding and treatment of B cell-related diseases, contributing significantly to the organization's research and development efforts in Summit, NJ.
Academic Role at Drexel University
Chris Huang served as an Adjunct Assistant Professor at Drexel University from 2006 to 2017. Over these 11 years, he played a critical role in educating students, mentoring junior scientists, postdocs, and graduate students, and contributing to the academic community through both teaching and research.
Early Career and Research Positions
In the early stages of his career, Chris Huang held various research-centric roles. Notably, he was a Principal Scientist at Janssen Inc. for 16 years, and a Research Fellow in Neurogenetics at Massachusetts General Hospital for 2 years. He also worked as a Research Assistant at Cold Spring Harbor Laboratory for 5 years. These positions provided a strong foundation in scientific research and development.
Educational Background and Certifications
Chris Huang obtained his PhD in Genetics from Stony Brook University, completing his studies from 1991 to 1997. He also earned a MS in Molecular Biology from the University of Science and Technology of China. His academic credentials are complemented by over 30 publications in peer-reviewed scientific journals and the holding of 3 US/International patents.